Advertisement

Topics

Genentech & Bristol-Myers Squibb Dominate Franchise Image, Overall Engagement Among Oncologists

11:51 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Merck, Novartis, Amgen and Celgene rank in the second tier Genentech and Bristol-Myers Squibb (BMS) lead oncology franchises in image and engagement according to oncologists, who give them top scores across multiple metrics....

Other Sources for this Article

Market Strategies International
Lisa Viselli, 734.779.6851
lisa.viselli@marketstrategies.com

NEXT ARTICLE

More From BioPortfolio on "Genentech & Bristol-Myers Squibb Dominate Franchise Image, Overall Engagement Among Oncologists"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...